AvalehtBAX • NYSE
add
Baxter International Inc
Viimane sulgemishind
33,14 $
Tänane vahemik
33,11 $ - 33,81 $
Aasta vahemik
31,60 $ - 44,01 $
Turuväärtus
17,20 mld USD
Keskmine maht
3,93 mln
P/E suhe
157,55
Dividendimäär
2,02%
Põhibörs
NYSE
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | sept 2024info | Y/Y muutus |
|---|---|---|
Käive | 2,70 mld | 3,85% |
Põhitegevusega seonduv kulu | 848,00 mln | 6,00% |
Puhastulu | 140,00 mln | −94,42% |
Puhaskasumimarginaal | 5,19 | −94,62% |
Puhaskasum aktsia kohta | 0,80 | 17,65% |
EBITDA | 353,00 mln | −2,22% |
Tõhus maksumäär | 11,59% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | sept 2024info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 1,42 mld | −75,47% |
Kogu vara | 26,68 mld | −12,98% |
Kõik kohustused | 18,73 mld | −16,70% |
Kogu omakapital | 7,94 mld | — |
Emiteeritud aktsiate arv | 510,59 mln | — |
Hinna ja väärtuse suhe P/B | 2,15 | — |
Varade tasuvus | 2,11% | — |
Kapitali tasuvus | 2,65% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | sept 2024info | Y/Y muutus |
|---|---|---|
Puhastulu | 140,00 mln | −94,42% |
Põhitegevuse rahakäive | — | — |
Investeeringute raha | — | — |
Finantseerimise raha | — | — |
Raha ja raha ekvivalentide muutus | — | — |
Tasuta rahavoog | — | — |
Teave
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis. Wikipedia
Tegevjuht
Asutatud
1931
Veebisait
Töötajate arv
60 000
